New diabetes drug under Real-World watch in pakistan
NCT ID NCT05164263
First seen Jan 31, 2026 · Last updated Jun 13, 2026 · Updated 11 times
Summary
This study looks at how safe and well-tolerated the diabetes medicine empagliflozin (taken with or without metformin) is for people with type 2 diabetes in Pakistan. About 2,000 adults aged 18 to 65 whose blood sugar is not well controlled will take the drug and be monitored for 6 months. Researchers will track side effects like low blood sugar, infections, and stomach issues, as well as changes in blood sugar and weight.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SAFETY ISSUES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Agha Khan univeristy hospital
RECRUITINGNairobi, Kenya, Kenya
Contact
-
Kabul University of Medical Sciences(KUMS)
COMPLETEDKabul, Afghanistan, Afghanistan
-
Lagos University Teaching Hospital
RECRUITINGLagos, Nigeria, Nigeria
Contact
Contact
Contact
-
NHK
COMPLETEDKandy, Kandy, Sri Lanka
-
National hospital Sri Lanka
COMPLETEDColombo, Colombo, Sri Lanka
-
Umar Diabetes Foundation
COMPLETEDIslamabad, Pakistan
Conditions
Explore the condition pages connected to this study.